BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 34418690)

  • 1. Coding variants in the PCNT and CEP295 genes contribute to breast cancer risk in Chinese women.
    Zhou J; Chen C; Zhao X; Jiang T; Jiang Y; Dai J; Chen J
    Pathol Res Pract; 2021 Sep; 225():153581. PubMed ID: 34418690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic polymorphisms in centrobin and Nek2 are associated with breast cancer susceptibility in a Chinese Han population.
    Wang H; Xie YT; Han JY; Ruan Y; Song AP; Zheng LY; Zhang WZ; Sajdik C; Li Y; Tian XX; Fang WG
    Breast Cancer Res Treat; 2012 Nov; 136(1):241-51. PubMed ID: 23001753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer association studies in a Han Chinese population using 10 European-ancestry-associated breast cancer susceptibility SNPs.
    Guan YP; Yang XX; Yao GY; Qiu F; Chen J; Chen LJ; Ye CS; Li M
    Asian Pac J Cancer Prev; 2014; 15(1):85-91. PubMed ID: 24528085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the breast cancer predisposition role of rare variants in genes associated with low-penetrance breast cancer risk SNPs.
    Li N; Rowley SM; Thompson ER; McInerny S; Devereux L; Amarasinghe KC; Zethoven M; Lupat R; Goode D; Li J; Trainer AH; Gorringe KL; James PA; Campbell IG
    Breast Cancer Res; 2018 Jan; 20(1):3. PubMed ID: 29316957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SNP rs2071095 in LincRNA H19 is associated with breast cancer risk.
    Cui P; Zhao Y; Chu X; He N; Zheng H; Han J; Song F; Chen K
    Breast Cancer Res Treat; 2018 Aug; 171(1):161-171. PubMed ID: 29737472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of CpG-SNPs in miRNA promoters and risk of breast cancer.
    Chen J; Jiang Y; Zhou J; Liu S; Qin N; Du J; Jin G; Hu Z; Ma H; Shen H; Dai J
    Gene; 2018 Apr; 651():1-8. PubMed ID: 29374520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer.
    Kabisch M; Lorenzo Bermejo J; Dünnebier T; Ying S; Michailidou K; Bolla MK; Wang Q; Dennis J; Shah M; Perkins BJ; Czene K; Darabi H; Eriksson M; Bojesen SE; Nordestgaard BG; Nielsen SF; Flyger H; Lambrechts D; Neven P; Peeters S; Weltens C; Couch FJ; Olson JE; Wang X; Purrington K; Chang-Claude J; Rudolph A; Seibold P; Flesch-Janys D; Peto J; dos-Santos-Silva I; Johnson N; Fletcher O; Nevanlinna H; Muranen TA; Aittomäki K; Blomqvist C; Schmidt MK; Broeks A; Cornelissen S; Hogervorst FB; Li J; Brand JS; Humphreys K; Guénel P; Truong T; Menegaux F; Sanchez M; Burwinkel B; Marmé F; Yang R; Bugert P; González-Neira A; Benitez J; Pilar Zamora M; Arias Perez JI; Cox A; Cross SS; Reed MW; Andrulis IL; Knight JA; Glendon G; Tchatchou S; Sawyer EJ; Tomlinson I; Kerin MJ; Miller N; ; ; Haiman CA; Schumacher F; Henderson BE; Le Marchand L; Lindblom A; Margolin S; Hooning MJ; Hollestelle A; Kriege M; Koppert LB; Hopper JL; Southey MC; Tsimiklis H; Apicella C; Slettedahl S; Toland AE; Vachon C; Yannoukakos D; Giles GG; Milne RL; McLean C; Fasching PA; Ruebner M; Ekici AB; Beckmann MW; Brenner H; Dieffenbach AK; Arndt V; Stegmaier C; Ashworth A; Orr N; Schoemaker MJ; Swerdlow A; García-Closas M; Figueroa J; Chanock SJ; Lissowska J; Goldberg MS; Labrèche F; Dumont M; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Brauch H; Brüning T; Ko YD; ; Radice P; Peterlongo P; Scuvera G; Fortuzzi S; Bogdanova N; Dörk T; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Devilee P; Tollenaar RA; Seynaeve C; Van Asperen CJ; Jakubowska A; Lubinski J; Jaworska-Bieniek K; Durda K; Zheng W; Shrubsole MJ; Cai Q; Torres D; Anton-Culver H; Kristensen V; Bacot F; Tessier DC; Vincent D; Luccarini C; Baynes C; Ahmed S; Maranian M; Simard J; Chenevix-Trench G; Hall P; Pharoah PD; Dunning AM; Easton DF; Hamann U
    Carcinogenesis; 2015 Feb; 36(2):256-71. PubMed ID: 25586992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Polymorphisms of microRNA genes and their association with breast cancer risk].
    Zhang P; Ma F; Xu B
    Zhonghua Zhong Liu Za Zhi; 2015 Jul; 37(7):501-7. PubMed ID: 26463325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variations within alternative splicing associated genes are associated with breast cancer susceptibility in Chinese women.
    Xu X; Yang J; Zhou W; Wang L; Lu Q; Wang X; Hang D; Liu X
    Gene; 2019 Jul; 706():140-145. PubMed ID: 31078657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of interleukin 10 polymorphisms on breast cancer susceptibility in Han women in Shaanxi Province.
    Li M; Yue C; Zuo X; Jin G; Wang G; Guo H; Wu F; Huang S; Zhao X
    PLoS One; 2020; 15(5):e0232174. PubMed ID: 32380517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of miRNA-binding-site SNPs of MRE11A, NBS1, RAD51 and RAD52 involved in HRR pathway genes and risk of breast cancer in China.
    Wu Z; Wang P; Song C; Wang K; Yan R; Li J; Dai L
    Mol Genet Genomics; 2015 Jun; 290(3):1141-53. PubMed ID: 25566853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inositol 1,4,5-trisphosphate receptor gene variants are related to the risk of breast cancer in a Chinese population.
    Chen J; Zhou J; Jiang Y; Wang Y; Chen C; Jiang T; Du J
    J Gene Med; 2023 Feb; 25(2):e3463. PubMed ID: 36350267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Novel Breast Cancer Risk Loci.
    Chan CHT; Munusamy P; Loke SY; Koh GL; Wong ESY; Law HY; Yoon CS; Tan MH; Yap YS; Ang P; Lee ASG
    Cancer Res; 2017 Oct; 77(19):5428-5437. PubMed ID: 28775167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rare coding variants and breast cancer risk: evaluation of susceptibility Loci identified in genome-wide association studies.
    Zhang Y; Long J; Lu W; Shu XO; Cai Q; Zheng Y; Li C; Li B; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2014 Apr; 23(4):622-8. PubMed ID: 24470074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variants in ultraconserved elements and risk of breast cancer in Chinese population.
    Shen H; Lu C; Jiang Y; Tang J; Chen W; Zhang H; Zhang Q; Wang J; Liang J; Hu Z; Shen H
    Breast Cancer Res Treat; 2011 Aug; 128(3):855-61. PubMed ID: 21331621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the Association of Eight Polymorphisms with Cancer Susceptibility in a Han Chinese Population.
    Dong Y; Chen J; Chen Z; Tian C; Lu H; Ruan J; Yang W
    PLoS One; 2015; 10(7):e0132797. PubMed ID: 26176862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer risk assessment with five independent genetic variants and two risk factors in Chinese women.
    Dai J; Hu Z; Jiang Y; Shen H; Dong J; Ma H; Shen H
    Breast Cancer Res; 2012 Jan; 14(1):R17. PubMed ID: 22269215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of functional germline variants in APOBEC3 and driver genes on breast cancer risk in Moroccan study population.
    Marouf C; Göhler S; Filho MI; Hajji O; Hemminki K; Nadifi S; Försti A
    BMC Cancer; 2016 Feb; 16():165. PubMed ID: 26920143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significant association between ERCC2 and MTHR polymorphisms and breast cancer susceptibility in Moroccan population: genotype and haplotype analysis in a case-control study.
    Hardi H; Melki R; Boughaleb Z; El Harroudi T; Aissaoui S; Boukhatem N
    BMC Cancer; 2018 Mar; 18(1):292. PubMed ID: 29544444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus.
    Horne HN; Chung CC; Zhang H; Yu K; Prokunina-Olsson L; Michailidou K; Bolla MK; Wang Q; Dennis J; Hopper JL; Southey MC; Schmidt MK; Broeks A; Muir K; Lophatananon A; Fasching PA; Beckmann MW; Fletcher O; Johnson N; Sawyer EJ; Tomlinson I; Burwinkel B; Marme F; Guénel P; Truong T; Bojesen SE; Flyger H; Benitez J; González-Neira A; Anton-Culver H; Neuhausen SL; Brenner H; Arndt V; Meindl A; Schmutzler RK; Brauch H; Hamann U; Nevanlinna H; Khan S; Matsuo K; Iwata H; Dörk T; Bogdanova NV; Lindblom A; Margolin S; Mannermaa A; Kosma VM; Chenevix-Trench G; ; Wu AH; Ven den Berg D; Smeets A; Zhao H; Chang-Claude J; Rudolph A; Radice P; Barile M; Couch FJ; Vachon C; Giles GG; Milne RL; Haiman CA; Marchand LL; Goldberg MS; Teo SH; Taib NA; Kristensen V; Borresen-Dale AL; Zheng W; Shrubsole M; Winqvist R; Jukkola-Vuorinen A; Andrulis IL; Knight JA; Devilee P; Seynaeve C; García-Closas M; Czene K; Darabi H; Hollestelle A; Martens JW; Li J; Lu W; Shu XO; Cox A; Cross SS; Blot W; Cai Q; Shah M; Luccarini C; Baynes C; Harrington P; Kang D; Choi JY; Hartman M; Chia KS; Kabisch M; Torres D; Jakubowska A; Lubinski J; Sangrajrang S; Brennan P; Slager S; Yannoukakos D; Shen CY; Hou MF; Swerdlow A; Orr N; Simard J; Hall P; Pharoah PD; Easton DF; Chanock SJ; Dunning AM; Figueroa JD
    PLoS One; 2016; 11(8):e0160316. PubMed ID: 27556229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.